Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD.
Devlin
Shane M
SM
Inflammatory Bowel Disease Center, The University of Calgary, Calgary, Alberta, Canada.
Dubinsky
Marla C
MC
D015415:Biomarkers; D005819:Genetic Markers; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D011379:Prognosis
D015415:Biomarkers; D005819:Genetic Markers